• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
COH 1.67% $293.02

COCHLEAR LIMITED - Charts / Financials

Cochlear Limited is an Australia-based company, which provides implantable hearing... Cochlear Limited is an Australia-based company, which provides implantable hearing solutions and sound processors. The Company is engaged in development, manufacture and commercialization of implantable hearing solutions. Its segments include Cochlear implants, Services (sound processor upgrades and other) and Acoustics. The Company’s products and services portfolio include Cochlear implant portfolio, Acoustic solutions portfolio, and Recipient support tools. Its Cochlear Connected Care solutions include Cochlear Nucleus SmartNav System, Cochlear Custom Sound Pro Fitting Software, Cochlear Link, Cochlear Remote Assist, and Cochlear Remote Check solution for cochlear implants. Its Cochlear implant portfolio include Cochlear Nucleus System. Its Acoustic solutions portfolio include Cochlear Osia System, and Cochlear Baha System. Its Recipient support tools include Cochlear Nucleus, Baha and Osia Smart Apps and Cochlear CoPilot App.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

refresh Created with Sketch. REFRESH
Last update - 15.59pm 21/11/2024 (20 minute delay) ?
Day
Open $300.33   Day High $302.50   Day Low $290.30
Daily Volume 136963
Bids   Sellers
Number Price Volume   Number Price Volume
1 $292.79 83   2 $293.09 629

Directors & Senior Management

Mr. Diggory William Howitt President, Chief Executive Officer, Executive Director
Mr. Stuart Sayers President, Asia Pacific & Latin America
Ms. Lisa Aubert President - North America
Mr. Anthony Bishop President - EMEA
Mr. Richard Brook President - EMEA and Latin American Region
Mr. Dean Phizacklea Senior Vice President - Global Strategic Marketing
Mr. Greg Bodkin Senior Vice President - Supply Chain & Operational Excellence
Ms. Jennifer Hornery Senior Vice President - People and Culture
Mr. Brian Kaplan Senior Vice President - Clinical Strategy and Innovation
Mr. Jan Janssen Chief Technology Officer
Ms. Alison Catriona Deans Non-Executive Independent Chairman of the Board
Ms. Caroline Clarke Non-Executive Director
Sir Michael Grenfell Daniell Non-Executive Director
Ms. Karen Lee Collett Penrose Non-Executive Director
Mr. Glen Francis Boreham Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
$293.02
Change
-4.980(1.67%)
Mkt cap ! $18.63B
Open High Low Value Volume
$300.33 $302.50 $290.30 $40.27M 136.9K

Buyers (Bids)

No. Vol. Price($)
1 83 $292.79
 

Sellers (Offers)

Price($) Vol. No.
$293.09 629 2
View Market Depth
Last trade - 16.10pm 21/11/2024 (20 minute delay) ?
Last
$292.65
  Change
-4.980 ( 1.75 %)
Open High Low Volume
$301.49 $301.49 $290.32 25631
Last updated 15.59pm 21/11/2024 ?
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.